InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,686.00
(
0.23%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.31
(
-0.03%
)
Bitcoin
54,357.67
(
-4.60%
)
Post# of 11034
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

brockabrella

Send PM Follow Ignore
Followers 0
Posts 10
Boards Moderated 0
Alias Born 09/09/2006

brockabrella

Re: None

Monday, 10/30/2006 11:57:15 PM

Monday, October 30, 2006 11:57:15 PM

Post# of 11034
CLBE should benefit from Merck's acquisition of RNAI today... Merck paid over a $ Billion to gobble up that RNAi stock. CLBE has a subsidiary that sells/markets to the RNAi sector... thus, CLBE may benefit from the attention being paid to this sector (finally)!

I'm amazed that CLBE hasn't already moved up, as other stem cell stocks have been hot recently... including SCAL.PK, STEM, CBAI, etc.

-b'brella
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up